Vanguard Group Inc Accelerate Diagnostics, Inc Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.64 - $1.03 $13,824 - $22,248	21,600 Added 0.75%	2,898,363 $2.35 Million
Q1 2023 May 15, 2023	BUY	$0.46 - $0.77 $8,148 - $13,639	17,714 Added 0.62%	2,876,763 $2.01 Million
Q4 2022 Feb 10, 2023	BUY	$0.51 - $17.1 $17,037 - $571,242	33,406 Added 1.18%	2,859,049 $2.03 Million
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $525,862 - $8.85 Million	520,656 Added 22.59%	2,825,643 $4.3 Million
Q2 2022 Aug 12, 2022	BUY	$0.54 - $1.41 $531,764 - $1.39 Million	984,749 Added 74.59%	2,304,987 $2.29 Million
Q1 2022 May 13, 2022	SELL	$1.4 - $5.15 $669,947 - $2.46 Million	-478,534 Reduced 26.6%	1,320,238 $1.9 Million
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $280,906 - $458,528	65,786 Added 3.8%	1,798,772 $9.39 Million
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $193,554 - $300,720	36,451 Added 2.15%	1,732,986 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$6.81 - $9.23 $11.6 Million - $15.7 Million	1,696,535 New	1,696,535 $13.7 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.